Skip to main content
VCbacked
Log inGet Started

Revel Pharmaceuticals

San Francisco, United States

Revel Pharmaceuticals develops therapeutics for multiple diseases of aging including osteoarthritis, kidney, and complications of diabetes.

$84K raised
Oct 2025
Venture - Series Unknown
BiotechnologyLife SciencePharmaceutical

Top Investors

GaingelsStarbloom CapitalKIZOO Technology CapitalTubus

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Revel Pharmaceuticals

How much funding has Revel Pharmaceuticals raised?
Revel Pharmaceuticals has raised $84K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2025.
Who are Revel Pharmaceuticals's investors?
Revel Pharmaceuticals's investors include Gaingels, Starbloom Capital, KIZOO Technology Capital, Tubus.
Where is Revel Pharmaceuticals headquartered?
Revel Pharmaceuticals is headquartered in San Francisco, United States.
What does Revel Pharmaceuticals do?
Revel Pharmaceuticals develops therapeutics for multiple diseases of aging including osteoarthritis, kidney, and complications of diabetes.
What stage is Revel Pharmaceuticals at?
Revel Pharmaceuticals is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Revel Pharmaceuticals — Funding & Investors." VCBacked, October 7, 2025, https://www.vcbacked.co/company/revel-pharmaceuticals. Accessed July 2, 2026.
APA
VCBacked. (2025). Revel Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/revel-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Revel Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/revel-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K